JACKSON THORNTON WEALTH MANAGEMENT, LLC
Position in CORT — Corcept Therapeutics Inc
CIK 1903880
MONTGOMERY, AL
Position in CORT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$217,548
New position
Shares Held
2,502
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#312
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACKSON THORNTON WEALTH MANAGEMENT, LLC holds $2,375,958 across 6 Biotechnology names. CORT ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
5,638 | $639,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
972 | $606,080 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
791 | $392,912 | |
| 4 | EXEL |
Exelixis, Inc.
|
5,744 | $312,530 | |
| 5 | CORT |
Corcept Therapeutics Inc
This page
|
2,502 | $217,548 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
3,631 | $207,765 |
All Filings in CORT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,548 | 2,502 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||